Flow Cytometry

#Flow Cytometry

Practical guide to get you started in flow cytometry

Flow cytometry is a powerful tool allowing you to detect, measure, and quantify single cells or particles in suspension as they pass through a laser. However, to produce impactful results, experiments must be designed with care. This guide takes you through the fundamentals of flow cytometry, provides useful practical advice… Read More

#News

#Biotechnology #CAR-T #Flow Cytometry #Tumour #Webinar

Webinar: Imaging for target discovery for CAR T cell therapy

In this free webinar, Dr. Christoph Herbel presents a newly developed workflow which combines flow cytometry–based screenings with high-parameter imaging to identify and validate new tumour markers in an unbiased approach.   The event, Kill the tumour, spare the healthy tissue. Ultra high-content imaging enables target discovery for CAR T cell therapy, was hosted by DDW and supported by Miltenyi Biotec.  It… Read More

#News #Trending News

#CAR-T #Cell therapy #Drug screening #Drug targets #Flow Cytometry #Tumour

How to assess the safety profile of potential CAR targets 

CAR T cell technology provides the foundation for established immunotherapies against certain types of blood cancer and holds great promise for the fight against many solid tumours too. One major drawback of conventional CAR T cell technology, which relies on a single target antigen, is the lack of tumour-associated antigens (TAAs) that… Read More

#News #Trending News

#CAR-T #Flow Cytometry #Tumour #Webinar

How to identify and evaluate new tumour markers 

Major advances have been achieved in targeted immunotherapy with significant clinical benefits for patients. However, on-target/off-tumour toxicity is still a major concern, which highlights the clinical need for better targets to improve the safety profile of immunotherapies.   On-target/off-tumour toxicity is mainly based on the expression of tumour-associated… Read More

#News #Trending News

#Biologics #Drug development #Flow Cytometry #Immunogenicity #Therapeutics

Cellular assays to bridge the gap in immunogenicity prediction 

Listen to this article on the DDW Podcast: Dr. Urmi Roy, Global Product Manager for Flow Cytometry Reagents, Miltenyi Biotec, explains why immunogenicity prediction is a key consideration for therapeutic development.  Biologic drugs as therapy have improved the treatment of many diseases, but their success is often tempered by antidrug antibodies (ADAs),… Read More

#Editor's Choice #Exclusive Content #News #Opinion

#Cancer immunotherapy #Flow Cytometry #Immuno-oncology #Webinar

Free webinar addresses bottlenecks in immuno-oncology therapies 

Within our drug discovery world, unless we have contact with clinical settings, it is easy to lose sight that our expertise, time, laboratory instruments, software, reagents, tools, workflows and procedures etc. are ultimately designed for the benefit of real-life patients.  Deriving Context from Immunological Data with Advanced Flow Cytometry… Read More

#News

#Biologics / Biotechnology #Cancer immunotherapy #Drug discovery #Flow Cytometry #Immuno-oncology #Webinar

Webinar offers insight into pharmacological reactions

Dr Nina Senutovitch, Senior Scientist, Sartorius, notes that more efficient and powerful tools are critical for furthering the development of highly target-specific immunotherapies, such as adoptive cell transfer therapies. These include Chimeric Antigen Receptor T cells (CAR-T), that harness an individual’s own immune system to attack cancerous cells. … Read More

#News #Trending News

#Biopharma #Cancer research #Cell therapy #Drug discovery #Flow Cytometry #Immuno-oncology #Immunology #Webinar

Learn about immunophenotyping and advanced cell function assays

Advances in treatments for human diseases, including cancer, rely on the ability to gain detailed information into the function, modulation, and variation of the immune system in response to stimuli or immunological challenge. Insights derived from these data have, for example, revolutionised cancer treatment by enabling the development of… Read More

#News

#Biologics / Biotechnology #Cancer immunotherapy #Drug discovery #Flow Cytometry #Immuno-oncology #Webinar

Are you investigating pharmacological reactions?

Dr Nina Senutovitch, Senior Scientist, Sartorius, notes that more efficient and powerful tools are critical for furthering the development of highly target-specific immunotherapies, such as adoptive cell transfer therapies. These include Chimeric Antigen Receptor T cells (CAR-T), that harness an individual’s own immune system to attack cancerous cells. … Read More

#News

#Cancer immunotherapy #Flow Cytometry #Immuno-oncology #Webinar

Addressing bottlenecks in immuno-oncology therapies 

Within our drug discovery world, unless we have contact with clinical settings, it is easy to lose sight that our expertise, time, laboratory instruments, software, reagents, tools, workflows and procedures etc. are ultimately designed for the benefit of real-life patients.  On 4 November 2021, 9AM PT; 12PM ET; 4PM… Read More

#News

#Biopharma #Cancer research #Cell therapy #Drug discovery #Flow Cytometry #Immuno-oncology #Immunology #Webinar

Deriving context from immunological data with flow cytometry – Webinar

Advances in treatments for human diseases, including cancer, rely on the ability to gain detailed information into the function, modulation, and variation of the immune system in response to stimuli or immunological challenge. Insights derived from these data have, for example, revolutionised cancer treatment by enabling the development of… Read More

#News

Business agreement
#Antibodies #Bioproduction #Flow Cytometry #Life sciences #Proteogenomics #Reagents

PerkinElmer to acquire BioLegend

PerkinElmer has entered into an agreement to acquire BioLegend, provider of life science antibodies and reagents, for approximately US$5.25 billion. The transaction will be the largest in PerkinElmer’s history and is expected to close by the end of the 2021 calendar year, subject to regulatory approvals and other customary closing… Read More

#News

#Data #Data science #Flow Cytometry #Pharma #Phenomics

Are scalable data science platforms the way forward?

Marilyn Matz, CEO of Paradigm4, and Zachary Pitluk, Vice President of Life Sciences at Paradigm4, explain why scalable data science platforms are key to supporting integrated analysis of single-cell genomic data sets.  As researchers approach the practical limits of flow cytometry and are challenged to simultaneously explore the thousands of… Read More

#Editor's Choice #Exclusive Content #News

#Data #Flow Cytometry

Bio-Rad introduces new dyes for flow cytometry

Bio-Rad has introduced three StarBright Dyes designed for flow cytometry applications. StarBright Violet 570, 670, and 710 Dyes offer improved brightness and precise excitation and emission spectra, making them suitable for use in multicolour flow cytometry panels. The line offers researchers a range of fluorescent nanoparticles conjugated to highly validated… Read More

#News

#Drug development #Drug discovery #Flow Cytometry #Miltenyi Biotec #Narrated podcasts

Flow Cytometry in Drug Discovery

This narrated article is called “Why flow cytometry in drug discovery is a real life-saver”, in which Roy, Global Product Manager at Miltenyi Biotec, outlines the benefits of flow cytometry, offering case study examples for its use. Capable of boasting high-throughput, accurate, multiparameter and highly reproducible results, it’s time for… Read More

#Podcasts

Cytometry
#Biologics / Biotechnology #Biotechnology #Drug development #Drug discovery #Flow Cytometry #High throughput screening #Podcast

DDW podcast: Flow cytometry in drug discovery

The latest free to listen to DDW podcast episode, titled Flow Cytometry in Drug Discovery, covers an article written by Urmi Roy for DDW, read aloud by Megan Thomas. This article is called “Why flow cytometry in drug discovery is a real life-saver”, in which Roy, Global Product Manager at… Read More

#News